Biofargo News & Blog

Chimeric Antigen Receptor T-cell (CAR-T) therapies have revolutionized hematological oncology. Yet, standardizing the in vitro expansion of human Peripheral Blood Mononuclear Cells (PBMCs) and engineered T cells remains a massive bottleneck for...

The Validation Bottleneck in Functional Genomics The current race in targeted protein degradation (PROTACs) and high-throughput CRISPR-Cas9 library screening is defined by one metric: speed to data. However, functional genomics screening hits...

A missed tail vein injection wastes an animal, a dose of compound, and your time — and it raises welfare concerns. The good news: failures almost always come from a short list...

Ask anyone who doses mice intravenously what their hardest strain is, and the answer is almost always the same: C57BL/6. The most widely used mouse strain in biomedical research is also the...

Tail vein injection is the standard route for intravenous (IV) dosing in mice — used in pharmacology, gene therapy vector delivery, imaging tracers and disease modeling. Done well, it is fast and...

If your lab does intravenous (IV) dosing in mice, the device you choose decides how many sticks you waste, how fast new students become reliable, and how much stress you put on...